Biorep Srl We are an independent “SERVICE PROVIDER” organization born in 2005 by the investment of Sapio Life (Gruppo Sapio), offering biorepository services to public and private research institutes, to the highest standards of quality and safety. A cell repository, or cell bank, is a collection of living cells maintained indefinitely at extremely low temperatures in a state of suspended animation. We are a technologically advanced infrastructure able to provide several services to meet the needs of the entire Scientific Community. The company’s objective is to become the leading biorepository service provider in Europe, with the aim of contributing to the advancement of medical research and scientific discovery, bringing today’s technology and science state-of-art to its portfolio of biorepository services and capabilities Thanks to an exclusive agreement with the Coriell Institute for Medical Research, the oldest and largest biorepository of the world, we are specialized in cell lines preparation, in nucleic acid extraction and long term storage in liquid nitrose (-196°C) and in refrigerators (-80°C) of any kind of biosamples, using procedures and standards developed by the Coriell in over 50 years of activity. BioRep and the Coriell together constitute one of the few “Global Biorepository” able to serve the pharmaceutical industries for world wide clinical trials. Our facility is specifically designed to give the utmost efficiency and security by implementing Coriell procedures and standards. In addition to the storage service, the company provides Cell Biology, Molecular Biology, Microbiology services developed in ISO 9001:2008 certified laboratories. The modern bank infrastructure for the storage of the biological material in liquid nitrogen is supported by the monitoring and control system, based on PLC (Programmable Logic Controller) Technology, able to register and certify all the operative parameters of critical instruments (liquid nitrogen tanks, mechanical freezers, incubators, laminar flow hoods, cold rooms…), and to activate a very sophisticated alarm system (24 h/day for 365 days/year) in case of emergency.  We are committed to a flexible and innovative approach for all its services to ensure client satisfaction. Presently, clinical trials for drug validation are now being performed globally; many disease screening studies are carried by associated research group using an enormous number of patients. In addition, the rapid progress on stem cell research will soon require the realization of facilities to properly preserve these cells for transplantation. For these reasons, there will be strong demands to store large quantities of biomaterials in safe biorepositories by the entire scientific community, and our copmany can become one of the reference centre in Europe able to satisfy these needs.